Literature DB >> 14990712

Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry.

Ayato Takada1, Kouki Fujioka, Makoto Tsuiji, Akiko Morikawa, Nobuaki Higashi, Hideki Ebihara, Darwyn Kobasa, Heinz Feldmann, Tatsuro Irimura, Yoshihiro Kawaoka.   

Abstract

Filoviruses cause lethal hemorrhagic disease in humans and nonhuman primates. An initial target of filovirus infection is the mononuclear phagocytic cell. Calcium-dependent (C-type) lectins such as dendritic cell- or liver/lymph node-specific ICAM-3 grabbing nonintegrin (DC-SIGN or L-SIGN, respectively), as well as the hepatic asialoglycoprotein receptor, bind to Ebola or Marburg virus glycoprotein (GP) and enhance the infectivity of these viruses in vitro. Here, we demonstrate that a recently identified human macrophage galactose- and N-acetylgalactosamine-specific C-type lectin (hMGL), whose ligand specificity differs from DC-SIGN and L-SIGN, also enhances the infectivity of filoviruses. This enhancement was substantially weaker for the Reston and Marburg viruses than for the highly pathogenic Zaire virus. We also show that the heavily glycosylated, mucin-like domain on the filovirus GP is required for efficient interaction with this lectin. Furthermore, hMGL, like DC-SIGN and L-SIGN, is present on cells known to be major targets of filoviruses (i.e., macrophages and dendritic cells), suggesting a role for these C-type lectins in viral replication in vivo. We propose that filoviruses use different C-type lectins to gain cellular entry, depending on the cell type, and promote efficient viral replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990712      PMCID: PMC353724          DOI: 10.1128/jvi.78.6.2943-2947.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells.

Authors:  K J Davis; A O Anderson; T W Geisbert; K E Steele; J B Geisbert; P Vogel; B M Connolly; J W Huggins; P B Jahrling; N K Jaax
Journal:  Arch Pathol Lab Med       Date:  1997-08       Impact factor: 5.534

Review 2.  Filovirus diseases.

Authors:  C J Peters; A S Khan
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

Review 3.  Experimental filovirus infections.

Authors:  S P Fisher-Hoch; J B McCormick
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

Review 4.  Classification, structure, and replication of filoviruses.

Authors:  H Feldmann; M P Kiley
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

Review 5.  Molecular pathogenesis of filovirus infections: role of macrophages and endothelial cells.

Authors:  H J Schnittler; H Feldmann
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

6.  GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases.

Authors:  V E Volchkov; S Becker; V A Volchkova; V A Ternovoj; A N Kotov; S V Netesov; H D Klenk
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

7.  A system for functional analysis of Ebola virus glycoprotein.

Authors:  A Takada; C Robison; H Goto; A Sanchez; K G Murti; M A Whitt; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.

Authors:  A Sanchez; S G Trappier; B W Mahy; C J Peters; S T Nichol
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

9.  Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells.

Authors:  Frédéric Baribaud; Stefan Pöhlmann; George Leslie; Frank Mortari; Robert W Doms
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

Authors:  Graham Simmons; Jacqueline D Reeves; Case C Grogan; Luk H Vandenberghe; Frédéric Baribaud; J Charles Whitbeck; Emily Burke; Michael J Buchmeier; Elizabeth J Soilleux; James L Riley; Robert W Doms; Paul Bates; Stefan Pöhlmann
Journal:  Virology       Date:  2003-01-05       Impact factor: 3.616

View more
  123 in total

1.  Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.

Authors:  Gopi S Mohan; Ling Ye; Wenfang Li; Ana Monteiro; Xiaoqian Lin; Bishu Sapkota; Brian P Pollack; Richard W Compans; Chinglai Yang
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.

Authors:  Andrea Marzi; Thomas Gramberg; Graham Simmons; Peggy Möller; Andrew J Rennekamp; Mandy Krumbiegel; Martina Geier; Jutta Eisemann; Nadine Turza; Bertrand Saunier; Alexander Steinkasserer; Stephan Becker; Paul Bates; Heike Hofmann; Stefan Pöhlmann
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.

Authors:  Yasuteru Sakurai; Andrey A Kolokoltsov; Cheng-Chang Chen; Michael W Tidwell; William E Bauta; Norbert Klugbauer; Christian Grimm; Christian Wahl-Schott; Martin Biel; Robert A Davey
Journal:  Science       Date:  2015-02-27       Impact factor: 47.728

4.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

5.  A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry.

Authors:  Anthony C Wong; Rohini G Sandesara; Nirupama Mulherkar; Sean P Whelan; Kartik Chandran
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

6.  Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein.

Authors:  Masahiro Kajihara; Andrea Marzi; Eri Nakayama; Takeshi Noda; Makoto Kuroda; Rashid Manzoor; Keita Matsuno; Heinz Feldmann; Reiko Yoshida; Yoshihiro Kawaoka; Ayato Takada
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

7.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

8.  Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events.

Authors:  Melinda A Brindley; Laura Hughes; Autumn Ruiz; Paul B McCray; Anthony Sanchez; David A Sanders; Wendy Maury
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding.

Authors:  Derek Dube; Matthew B Brecher; Sue E Delos; Sean C Rose; Edward W Park; Kathryn L Schornberg; Jens H Kuhn; Judith M White
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

10.  Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.

Authors:  Chantelle L Hood; Jonathan Abraham; Jeffrey C Boyington; Kwanyee Leung; Peter D Kwong; Gary J Nabel
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.